Betaville

Burnt fingers - part 2

Market punters that like to bet on the next takeover deal are likely to be experiencing burnt fingers for the second time in a week.

That's because the outgoing chairman of SOBI, a Sweden-based rare disease drug developer, slotted 8m shares last night, suggesting the company has not been approached by buyer.

Still, I guess it's quite possible a potential predator is working on a plan to pounce on SOBI, which last year held talks with Pfizer, but Bo Jesper Hansen has no idea about it.....